Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2012 Filed Feb 4, 2013 21:36 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 71,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006004 · doc5.xml · nonDerivative · entry 6 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,465 Read SEC document |
| November 19, 2012 Filed Feb 4, 2013 21:37 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
GiftCommon Stock | 105,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006005 · doc5.xml · nonDerivative · entry 2 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · Irrevocable Family Trust Disclosed balance after: 105,836 F1 · ownership.nature: Irrevocable family trust for benefit of wife and children. Read SEC document |
| November 19, 2012 Filed Feb 4, 2013 21:37 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
GiftCommon Stock | 105,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006005 · doc5.xml · nonDerivative · entry 1 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,337 Read SEC document |
| November 01, 2012 Filed Feb 4, 2013 21:36 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 10,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006004 · doc5.xml · nonDerivative · entry 5 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,965 Read SEC document |
| October 24, 2012 Filed Nov 7, 2012 20:24 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
SaleCommon Stock | 10,000 | $50.45 | $504,500.00 |
DisclosureSEC source: 0001209191-12-052107 · doc4.xml · nonDerivative · entry 1 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,620 Read SEC document |
| October 01, 2012 Filed Oct 2, 2012 19:10 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-047456 · doc4.xml · derivative · entry 5 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2012-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2012 Filed Oct 2, 2012 19:10 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
Tax withholdingCommon Stock | 4,643 | $47.41 | $220,124.63 |
DisclosureSEC source: 0001209191-12-047456 · doc4.xml · nonDerivative · entry 2 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,601 Read SEC document |
| October 01, 2012 Filed Oct 2, 2012 19:10 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
Exercise / conversionCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-047456 · doc4.xml · nonDerivative · entry 1 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2012 Filed Oct 30, 2012 13:46 UTC |
HANISH ARNOLD CChief Accounting Officer
|
GiftCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-050900 · doc4.xml · nonDerivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,611 Read SEC document |
| August 01, 2012 Filed Aug 1, 2012 19:13 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $44.16 | $220,800.00 |
DisclosureSEC source: 0001209191-12-039819 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,012 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012. Read SEC document |
| July 25, 2012 Filed Feb 4, 2013 21:36 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006004 · doc5.xml · nonDerivative · entry 9 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 53,086 F1 · ownership.nature: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| July 25, 2012 Filed Feb 4, 2013 21:36 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006004 · doc5.xml · nonDerivative · entry 4 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,272 Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 19:34 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $43.00 | $215,000.00 |
DisclosureSEC source: 0001209191-12-036813 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,012 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012. Read SEC document |
| July 01, 2012 Filed Jul 3, 2012 19:39 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Tax withholdingCommon Stock | 1,031 | $42.91 | $44,240.21 |
DisclosureSEC source: 0001209191-12-036828 · doc4.xml · nonDerivative · entry 1 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,404 Read SEC document |
| June 14, 2012 Filed Jun 18, 2012 13:31 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
SaleCommon Stock | 2,125 | $41.60 | $88,400.00 |
DisclosureSEC source: 0001209191-12-034175 · doc4.xml · nonDerivative · entry 1 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,744 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2012. Read SEC document |
| June 07, 2012 Filed Feb 4, 2013 21:36 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006004 · doc5.xml · nonDerivative · entry 3 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,428 Read SEC document |
| June 01, 2012 Filed Jun 4, 2012 19:52 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $40.60 | $203,000.00 |
DisclosureSEC source: 0001209191-12-031898 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,012 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012. Read SEC document |
| May 30, 2012 Filed Feb 4, 2013 21:36 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 11,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006004 · doc5.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,037 Read SEC document |
| May 18, 2012 Filed May 21, 2012 19:20 UTC |
HANISH ARNOLD CChief Accounting Officer
|
SaleCommon Stock | 1,295 | $40.49 | $52,434.55 |
DisclosureSEC source: 0001209191-12-029433 · doc4.xml · nonDerivative · entry 2 HANISH ARNOLD C · CIK 0001233253 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,747 Read SEC document |
| May 14, 2012 Filed May 15, 2012 15:38 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
SaleCommon Stock | 2,000 | $41.04 | $82,080.00 |
DisclosureSEC source: 0001209191-12-028140 · doc4.xml · nonDerivative · entry 1 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,869 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2012. Read SEC document |
| May 02, 2012 Filed May 21, 2012 19:20 UTC |
HANISH ARNOLD CChief Accounting Officer
|
GiftCommon Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-029433 · doc4.xml · nonDerivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,042 Read SEC document |
| May 01, 2012 Filed May 2, 2012 14:09 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $41.32 | $206,600.00 |
DisclosureSEC source: 0001209191-12-025306 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,012 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012. Read SEC document |
| April 27, 2012 Filed Feb 4, 2013 21:36 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 5,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006004 · doc5.xml · nonDerivative · entry 13 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · John C. Lechleiter 2010.3-2 GRAT Disclosed balance after: 0 F3 · ownership.nature: Grantor retained annuity trust established by reporting person. Reporting person is trustee. Read SEC document |
| April 17, 2012 Filed Apr 19, 2012 17:24 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
SaleCommon Stock | 2,000 | $40.00 | $80,000.00 |
DisclosureSEC source: 0001209191-12-023608 · doc4.xml · nonDerivative · entry 1 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,869 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2012. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 17:37 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 5,000 | $40.30 | $201,500.00 |
DisclosureSEC source: 0001209191-12-021779 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,012 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012. Read SEC document |
| March 13, 2012 Filed Feb 4, 2013 21:36 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
GiftCommon Stock | 14,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006004 · doc5.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,074 Read SEC document |
| March 12, 2012 Filed Mar 13, 2012 19:00 UTC |
Tapiero JacquesSVP&Pres., Emerging Markets
|
SaleCommon Stock | 2,000 | $39.60 | $79,200.00 |
DisclosureSEC source: 0001209191-12-017720 · doc4.xml · nonDerivative · entry 1 Tapiero Jacques · CIK 0001479078 · SVP&Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,869 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2012. Read SEC document |
| March 07, 2012 Filed Feb 4, 2013 21:40 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 56,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006009 · doc5.xml · nonDerivative · entry 2 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 168,640 Read SEC document |
| March 07, 2012 Filed Feb 4, 2013 21:40 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 56,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-006009 · doc5.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 13, 2012 Filed Feb 15, 2012 17:08 UTC |
Simmons Jeffrey NSVP&Pres.,Elanco Animal Health
|
SaleCommon Stock | 7,900 | $38.85 | $306,915.00 |
DisclosureSEC source: 0001209191-12-010305 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,182 Read SEC document |
| February 02, 2012 Filed Feb 2, 2012 20:39 UTC |
Rice Derica WEVP-Global Services and CFO
|
SaleCommon Stock | 3,800 | $39.61 | $150,518.00 |
DisclosureSEC source: 0001209191-12-006934 · doc4.xml · nonDerivative · entry 4 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,196 F3 · price: This transaction was executed in multiple trades at prices ranging from $39.61 to $39.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:39 UTC |
Rice Derica WEVP-Global Services and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 87,924 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006934 · doc4.xml · derivative · entry 8 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,924 shares Expires 2012-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:39 UTC |
Rice Derica WEVP-Global Services and CFO
|
SaleCommon Stock | 17,584 | $39.85 | $700,722.40 |
DisclosureSEC source: 0001209191-12-006934 · doc4.xml · nonDerivative · entry 3 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,996 F1 · kind: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2011. F2 · price: This transaction was executed in multiple trades at prices ranging from $39.83 to $39.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:39 UTC |
Rice Derica WEVP-Global Services and CFO
|
Tax withholdingCommon Stock | 35,917 | $39.74 | $1,427,341.58 |
DisclosureSEC source: 0001209191-12-006934 · doc4.xml · nonDerivative · entry 2 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,580 Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:39 UTC |
Rice Derica WEVP-Global Services and CFO
|
Exercise / conversionCommon Stock | 87,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006934 · doc4.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:40 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 58,616 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006935 · doc4.xml · derivative · entry 5 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,616 shares Expires 2012-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:40 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
Tax withholdingCommon Stock | 24,309 | $39.74 | $966,039.66 |
DisclosureSEC source: 0001209191-12-006935 · doc4.xml · nonDerivative · entry 2 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,063 Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:40 UTC |
ARMITAGE ROBERT ASr. VP and General Counsel
|
Exercise / conversionCommon Stock | 58,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006935 · doc4.xml · nonDerivative · entry 1 ARMITAGE ROBERT A · CIK 0001233249 · Sr. VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:41 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 219,812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006936 · doc4.xml · derivative · entry 7 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 219,812 shares Expires 2012-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:41 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
Tax withholdingCommon Stock | 91,157 | $39.74 | $3,622,579.18 |
DisclosureSEC source: 0001209191-12-006936 · doc4.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,519 Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:41 UTC |
LECHLEITER JOHN CDirector · Chairman, President, and CEO
|
Exercise / conversionCommon Stock | 219,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006936 · doc4.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:43 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
Exercise / conversionRestricted Stock Unit · Derivative | 87,924 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006939 · doc4.xml · derivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,924 shares Expires 2012-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:43 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
Tax withholdingCommon Stock | 36,463 | $39.74 | $1,449,039.62 |
DisclosureSEC source: 0001209191-12-006939 · doc4.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,647 Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:43 UTC |
Carmine Bryce D.EVP and Pres, Lilly Bio-Meds
|
Exercise / conversionCommon Stock | 87,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006939 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:43 UTC |
Deane Frank MPresident, Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 37,368 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006941 · doc4.xml · derivative · entry 4 Deane Frank M · CIK 0001401222 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,368 shares Expires 2012-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:43 UTC |
Deane Frank MPresident, Mfg. Operations
|
Tax withholdingCommon Stock | 15,497 | $39.74 | $615,850.78 |
DisclosureSEC source: 0001209191-12-006941 · doc4.xml · nonDerivative · entry 2 Deane Frank M · CIK 0001401222 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,995 Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:43 UTC |
Deane Frank MPresident, Mfg. Operations
|
Exercise / conversionCommon Stock | 37,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006941 · doc4.xml · nonDerivative · entry 1 Deane Frank M · CIK 0001401222 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:44 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,474 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006943 · doc4.xml · derivative · entry 4 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,474 shares Expires 2012-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:44 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Tax withholdingCommon Stock | 5,252 | $39.74 | $208,714.48 |
DisclosureSEC source: 0001209191-12-006943 · doc4.xml · nonDerivative · entry 2 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,435 Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:44 UTC |
Peterson Barton RSr. VP, Corp. Affairs & Comm.
|
Exercise / conversionCommon Stock | 16,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006943 · doc4.xml · nonDerivative · entry 1 Peterson Barton R · CIK 0001466550 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.